The spinal cord stimulators market has grown significantly in recent years as a result of the rising incidence of chronic pain conditions and the rising demand for non-pharmaceutical pain management techniques. Medical devices known as spinal cord stimulators (SCS) are used to treat conditions like failed back surgery syndrome, complex regional pain syndrome, and neuropathic …
Category Archives: Healthcare Trends
Laser Therapy Devices Market to reach US$ 7 Billion by 2033: Witness Steady Growth in the Coming Decade | FMI
The Laser Therapy Devices Market size is estimated to be valued at US$ 3 billion in 2023 and is expected to reach US$ 7 billion by 2033. The adoption of laser therapy devices is likely to advance at a CAGR of 8.8% during the forecast period. Future Market Insights’ (FMI) latest report on the global Laser Therapy Devices …
Sports Medicine Market to Reach US$ 11.4 Billion by 2032, Fuelled by Growing Demand for Wellness and Winning | FMI
According to estimates, the Sports Medicine Market will be worth US$ 6.8 billion in 2022. Expanding at a CAGR of 5.3%, reaching US$ 11.4 Billion by 2032. Body reconstruction products would control a market share of around 81.3% in 2021, according to the estimate. The market for sports medicine was worth approximately US$ 6.5 billion …
Downstream Processing: A Critical Step in the Development of Bioproducts for A Circular Economy 11.3% CAGR Market Growth by 2032 | FMI Insight
The extraction, purification, and refinement of important bioproducts are crucial tasks for the downstream processing market in the dynamic fields of industrial biotechnology and biopharmaceuticals. This crucial but frequently skipped phase makes ensuring that biopharmaceuticals, enzymes, biofuels, and other biotechnological goods are as effective and high-quality as possible when they are delivered to consumers. Downstream …
Rising Adoption of Membrane Filters in Various Industries May Boost the Pharmaceutical Filtration Market at a CAGR of 8.9% from 2023 to 2033
The pharmaceutical filtration market is likely to hold a valuation of US$ 45.08 billion by 2033. As of 2023, the market is anticipated to be US$ 19.19 billion. With advancements in the healthcare industry, the pharmaceutical filtration market is expected to grow outstandingly at a CAGR of 8.9% from 2023 to 2033. Pharmaceutical filtration is …
Molecular Imaging Pioneers are redefining the Possibilities of Non-Invasive Diagnosis, With FMI Predicting a CAGR of 11% for the Market By 2033
According to forecasts, the Molecular Imaging Market is expected to be US$ 5,437.16 million in 2023 and US$ 15,457.48 million by 2033. The need for early illness diagnosis is increasing due to the rising incidence of numerous chronic diseases like cancer and other genetic disorders, which is anticipated to fuel the expansion of the worldwide …
Multiplex Biomarker Imaging Is a Key Technology Enabling Precision Medicine and Personalized Diagnostics, and Its Market is expected to reach US$ 1,041.7 Million By 2029
The global multiplex biomarker imaging market has estimated to be worth USD 475.2 Million in 2022 and is expected to reach US$ 1,041.7 million by 2029, according to a recent industry report by Future Market Insights (FMI). The increased need for sophisticated immunofluorescence techniques that aid in better tumour detection and management at the cellular …
Demand For Dermal Fillers and Botulinum Toxin is Expected To Surge in the Coming Years, Reaching a Market Value of US$ 10.5 Billion By 2032
The Dermal Fillers And Botulinum Toxin Market size is expected to reach a valuation of US$ 5.9 Billion by the end of 2022, and further expand at a CAGR of 6.1% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 10.5 Billion by the end of 2032. Botulinum toxin is currently leading the dermal fillers and botulinum toxin …
Global Diabetic Macular Edema Market is Projected to Witness Steady Growth a CAGR Of 1.2%, To Reach a Valuation of US$ 4.2 Billion By 2032
The global Diabetic Macular Edema Market Size is expected to reach a valuation of US$ 3.7 Billion by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Billion by the end of 2032. Anti-VEGF drugs are the current standard of care for DME, and they …
Farm Animal Drugs Market to Expand at CAGR of 5.5%, Underpinned By Rising Demand for Animal Healthcare Products | FMI
The farm animal drugs market is anticipated to reach US$ 17.2 billion by the end of 2022. By the end of 2032, the market is anticipated to be valued US$ 29.4 billion, growing at a CAGR of 5.5% from 2022 to 2032. Approximately 92.4% of the market in 2021 will be dominated by livestock animals. …